Prognostic role of coronary flow reserve for left ventricular functional improvement after cardiac resynchronization therapy in patients with dilated cardiomyopathy

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 12, 2014, Pages 1344-1349

  Dikic, Ana Djordjevic ^a   Nikcevic, Gabrijela ^a   Raspopovic, Srdjan ^a   Jovanovic, Velibor ^a   Tesic, Milorad ^a   Beleslin, Branko ^a   Stepanovic, Jelena ^a   Giga, Vojislav ^a   Milasinovic, Goran ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cardiac resynchronization therapy; Coronary flow reserve; Dilated cardiomyopathy

Indexed keywords

ADENOSINE;

ADENOSINE-INDUCED HYPEREMIA; ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HUMAN; PRIORITY JOURNAL; PROGNOSIS; QRS INTERVAL; STRESS ECHOCARDIOGRAPHY; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY; AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY, DILATED; FEMALE; FRACTIONAL FLOW RESERVE; HEART VENTRICLE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSPECTIVE STUDY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84961290590     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jeu136     Document Type: Article

References (28)

1. Stern J, Heist EK, Murray L, Alabiad C, Chung J, Picard MH et al. Elevated estimated pulmonary artery systolic pressure is associated with an adverse clinical outcome in patients receiving cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007; 30:603-7.
2. Bleeker GB, Schalij MJ, Van DerWall EE, Bax JJ. Postero-lateral scar tissue resulting in non-response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006; 17:899-901.
3. MullensW, Grimm RA, VergaT, DresingT, Starling RC, Wilkoff BL et al. Insights from a cardiac resynchronization optimization clinic as a part of heart failure disease management program. J Am Coll Cardiol 2009;53:765-73.
4. Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, Steedijk P et al. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy. Am J Cardiol 2004;93:860-3.
5. Hawkins MN, Petrie CM, Burgess IM, Mc Murray JVJ. Selecting patients for cardiac resynchronization therapy. The fallacy of echocardiographic dyssynchrony. J Am Coll Cardiol 2009;53:1944-59.
6. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002;105:186-93.
7. Rigo F, Gherardi S, Galderisi M, Pratali L, Cortigiani L, Sicari R et al. The prognostic impact of coronary flow reserve assessed by Doppler echocardiography in nonischemic dilated cardiomyopathy. Eur Heart J 2006;27:1319-23.
8. Rigo F, Gherardi S, Galderisi M, Sicari R, Picano E. The independent prognostic value of contractile and coronary flow reserve determined by dipyridamole stress echocardiography in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2007; 99:1154-8.
9. Knaapen P, van Campen LM, de Cock CC, Gö tte MJ, Visser CA, Lammertsma AA et al. Effects of cardiac resynchronization therapy on myocardial perfusion reserve. Circulation 2004;110:646-51.
10. Nowak B, Sinha AM, Schaefer WM, Koch KC, Kaiser HJ, Hanrath P et al. Cardiac resynchronization therapy homogenizes myocardial glucose metabolism and perfusion in dilated cardiomyopathy and left bundle branch block. J Am Coll Cardiol 2003; 41:1523-8.
11. Lindner O, Vogt J, Kammeier A, Wielepp P, Holzinger J, BallerDet al. Effect of cardiac resynchronisation therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischemic and ischemic cardiomyopathy. Eur Heart J 2005;26:70-6.
12. Ypenburg C, Roes SD, Bleeker GB, Kaandorp TA, de Roos A, Schalij MJ et al. Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol 2007;99:567-60.
13. Lehrke S, Lossnitzer D, Schob M, Steen H, Merten C, Kemmling H et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischemic dilated cardiomyopathy. Heart 2011;97:727-32.
14. Tsagalou PE, Anastasiou-Nana M, Agapitos E, Gika A, Drakos GS, Terrovitis VJ et al. Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. JACC 2008;52:1391-8.
15. Vanderheyden M, Bartunek J, Verstreken S, Mortier L, Goethals M, de Bruyne B. Non-invasive assessment of coronaryflowreserve in idiopathic dilated cardiomyopathy: hemodynamic correlations. Eur J Echocardiogr 2005;6:47-53.
16. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH et al. Endotheliumdependent dilatation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990;81:772-9.
17. Nitenberg A, Foult JM, Blanchet F, Zouioueche S. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. Am J Cardiol 1985;55:743-54.
18. Skalidis EI, Kochiadakis GE, Koukoraki SI, Parthenakis FI, Karkavitsas NS, Vardas PE. Phasic coronary flow pattern and flow reserve in patients with left bundle branch block and normal coronary arteries. J Am Coll Cardiol 1999;33:1338-46.
19. Neglia D, Parodi O, Gallopin M, Sambuceti G, Gioretti A, Pratali L et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation 1995;92:796-804.
20. Skalidis E, Parthenakis F, Patrianakos A,Hamilos M, Vardas P. Regional coronary flow and contractile reserve in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004;44:2027-32.
21. van den Heuvel AFM, van Veldhusein DJ, van der Wall EE, Blanksma PK, Siebelink HMJ, VaalburgWM et al. Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2000;35:19-28.
22. Dini FL, Ghiadoni L, Conti U, Stea F, Buralli S, Taddei S et al. Coronary flow reserve in idiopathic dilated cardiomyopathy: relation with left ventricular wall stress, natriuretic peptides and endothelial dysfunction. J Am Soc Echocardiogr 2009;22:354-60.
23. O'Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach SL et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 1987;76: 1214-23.
24. Valzania C, Gadler F, Winter R, Braunschweig F, Brodin LA, Gudmundsson P et al. Effects of cardiac resynchronization therapy on coronary blood flow: evaluation by transthoracic Doppler echocardiography. Eur J Heart Fail 2008;10:514-20.
25. Auricchio A, Stellbrink C, Sack S, Block M, Vogt J, Bakker P et al. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002;39: 2026-33.
26. Flevari P, Theodorakis G, Paraskevaidis I, Kolokathis F, Kosotopoulou A, Leftheriotis D et al. Coronary and peripheral blood flow changes following biventricular pacing and their relation to heart rate improvement. Europace 2006;8:44-50.
27. Saraste M, Koskenvuo J, Knuuti J, Toikka J, Laine H, Niemi P et al. Coronary flow reserve measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol 2001;23: 114-22.
28. Rigo F, Ciampi Q, Ossena G, Grolla E, Picano E, Sicari R. Prognostic value of left and right coronary flow reserve assessment in nonischemic dilated cardiomyopathy by transthoracic Doppler echocardiography. J Cardiac Fail 2011;17:39-46.